# Sensitivity to Intravenous Nicotine: Genetic Moderators

> **NCT00969137** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 213 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** saline
- **DRUG:** Nicotine

## Key facts

- **NCT ID:** NCT00969137
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-02
- **Primary completion:** 2016-06-01
- **Final completion:** 2016-06-01
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969137, "Sensitivity to Intravenous Nicotine: Genetic Moderators". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00969137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*